In respiratory specimens, the proportion of no clinical benefit in the BALF by mNGS was lower than in ETA, although this did not reach statistical significance (5.7% vs 15.4%, P = 0.268) ( Supplementary Figure 8 ).
← all excerpts
Diagnostic Value and Clinical Application of Metagenomic Next-Generation Sequencing for Infections in Critically Ill Patients.
1
0.2680
0.2680